Moreover, gastric NETs have been described in patients with elevated gastrin due to long-term treatment with inhibitors of gastric acid secretion, particularly proton pump inhibitors [70,71,72,73]. The gene discussed is ATP4A; the disease is gastric neuroendocrine tumor, well differentiated, low or intermediate grade.